Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
It does not constitute personal medical advice and must not replace a formal consultation, diagnosis, or treatment plan from a qualified healthcare provider
It shouldnt be used as the only way to assess health
All protocols are accessed through guided, third-party research programs with clinician oversight
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
US$ 25.32
US$ 26.84
US$ 27.07
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
